Switch to Europe/Worldwide website Switch to German website Switch to French website Switch to OriGene Technologies, Inc. (North America)
Home » Target » CRK antibody

CRK antibody

(reset)

Principal name

CRK antibody

Alternative names for CRK antibody

Proto-oncogene C-crk, p38, Adapter molecule crk

SwissProt ID

P46108 (Human), Q04929 (Chick), Q63768 (Rat), Q64010 (Mouse)

Gene ID

1398 (CRK), 12928 (Crk), 54245

Ncbi ID

9606, NP_005197, NP_005197.3, NM_005206, NP_058431, NP_598417.2, NM_133656, NM_019302, NM_016823

Available reactivities

Hu (Human), Ms (Mouse), Rt (Rat)

Available hosts

Mouse, Rabbit

Available applications

Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P), Dot blot (Dot), ELISA (detection) (E(detection))

Background of CRK antibody

The Crk family of adapter proteins including Crk II, Crk I and Crk L consist mostly of SH2 and SH3 domains. Through the interactions between SH2 domain and phosphotyrosine residues and/or between SH3 domain and proline- rich motifs, they are involved in a variety of signaling cascades. Crk I and Crk II are encoded by the same gene, which undergoes alternative splicing to yield these two proteins, but differ in their biological activities. Crk II has less transforming activity than Crk I, although both Crk I and Crk II bind to many tyrosine-phosphorylated proteins that bind to GRB2. In addition, Crk II becomes rapidly tyrosine-phosphorylated in response to stimulation with insulin-like growth factor-I (IGFI) and might be involved in the IGF-I receptor signalling pathway. The gene encoding Crk I and II maps to human chromosome 17p13, a region which demonstrates frequent deletion or loss of heterozygosity in a wide range of human cancers.

General readings

Muir TW., et al (2006) Biochemistry. 45(29):8874-84.
Inagaki F., et al. (2007) Nat Struct Mol Biol. 14(6):503-10.

AP06075PU-N - CRK
Immunohistochemical analysis in paraffin-embedded human lung carcinoma tissue using CRK antibody (Cat.-No. AP06075PU-N).
AP06075PU-N - CRK
Western blot analysis in extracts from Hela cells using CRK antibody (Cat.-No. AP06075PU-N).
PAB0446 - CRK
Dot blot analysis of CRK (phospho S41) polyclonal antibody ( Cat # PAB0446 ) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentration was 0.5 µg/ml. P-Pab : phospho-antibody; P-Peptide : phospho-peptide; NP-Peptide : non-phospho-peptide.
AP12756PU-N - CRK
Dot blot analysis of Phospho-CRK-S41 polyclonal antibody (Cat#AP12756PU-N) on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentration was 0.5ug per ml. P-Pab: phospho-antibody; P-Peptide: phospho-peptide; NP-Peptide: non-phospho-peptide.
H00001398-B01 - CRK
Western Blot analysis of CRK expression in transfected 293T cell line (H00001398-T02) by CRK MaxPab polyclonal antibody.Lane 1: CRK transfected lysate(22.90 KDa).Lane 2: Non-transfected lysate.
H00001398-D01P - CRK
Proximity Ligation Analysis (PLA) of protein-protein interactions between CRK and SHC1 Mahlavu cells were stained with anti-CRK rabbit purified polyclonal 1:1200 and anti-SHC1 mouse monoclonal antibody 1:50. Signals were detected by Duolink® 30 Detection Kit 613(red), and nuclei were counterstained with DAPI (blue). Each red dot represents the detection of protein-protein interaction complex.
H00001398-D01P - CRK
Proximity Ligation Analysis (PLA) of protein-protein interactions between CRK and SOS1 HeLa cells were stained with anti-CRK rabbit purified polyclonal 1:1200 and anti-SOS1 mouse monoclonal antibody 1:50. Signals were detected by Duolink® 30 Detection Kit 613(red), and nuclei were counterstained with DAPI (blue). Each red dot represents the detection of protein-protein interaction complex.
H00001398-D01P - CRK
Western Blot analysis of CRK expression in transfected 293T cell line (H00001398-T02) by CRK MaxPab polyclonal antibody.Lane 1: CRK transfected lysate(22.90 KDa).Lane 2: Non-transfected lysate.
H00001398-B01P - CRK
Proximity Ligation Analysis (PLA) of protein-protein interactions between FLT1 and CRK. Huh7 cells were stained with anti-FLT1 rabbit purified polyclonal 1:600 and anti-CRK mouse purified polyclonal antibody 1:100. Signals were detected by Duolink® 30 Detection Kit 613(red), and nuclei were counterstained with DAPI (blue). Each red dot represents the detection of protein-protein interaction complex.
H00001398-B01P - CRK
Western Blot analysis of CRK expression in transfected 293T cell line (H00001398-T02) by CRK MaxPab polyclonal antibody.Lane 1: CRK transfected lysate(22.90 KDa).Lane 2: Non-transfected lysate.
AR09705PU-N - CRK
AR09705PU-N - CRK
Recombinant human CRK, 1-204aa, His-tagged
AP20934PU-N - CRK
Immunohistochemistry (IHC) analyzes of p-Crk2 antibody (Cat.-No.: AP20934PU-N) in paraffin-embedded human lung adenocarcinoma tissue.
AP21022PU-N - CRK
Immunohistochemistry (IHC) analyzes of Crk2 antibody (Cat.-No.: AP21022PU-N) in paraffin-embedded human lung adenocarcinoma tissue.
A0066-1 - CRK
Immunofluorescence analysis of HuvEc cells, using CrkII (Phospho-Tyr221) Antibody. The picture on the right is treated with the synthesized peptide.
A0066-1 - CRK
Western blot analysis of extracts from COS7 cells, using CrkII (Phospho-Tyr221) Antibody. The lane on the right is treated with the synthesized peptide.
B0066-1 - CRK
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using CrkII (Ab-221) Antibody. The picture on the right is treated with the synthesized peptide.
B0066-1 - CRK
Immunofluorescence analysis of HuvEc cells, using CrkII (Ab-221) Antibody. The picture on the right is treated with the synthesized peptide.
B0066-1 - CRK
Western blot analysis of extracts from COS7 cells, using CrkII (Ab-221) Antibody. The lane on the right is treated with the synthesized peptide.
AM06667SU-N - CRK
Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using CRK mouse mAb with DAB staining.
AM06667SU-N - CRK
Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CRK mouse mAb with DAB staining.
AM06667SU-N - CRK
Immunofluorescence analysis of 3T3-L1 cells using CRK mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.
AM06667SU-N - CRK
Western blot analysis using CRK mAb against human CRK (AA: 1-204) recombinant protein. (Expected MW is 48.4 kDa)
AM06667SU-N - CRK
Western blot analysis using CRK mAb against HEK293 (1) and CRK(AA: 1-204)-hIgGFc transfected HEK293 (2) cell lysate.
AM06667SU-N - CRK
Red: Control Antigen (100ng)Purple: Antigen (10ng)Green: Antigen (50ng)Blue: Antigen (100ng)
AM06667SU-N - CRK
Flow cytometric analysis of MCF-7 cells using CRK mouse mAb (blue) and negative control (red).
AM06668SU-N - CRK
Immunohistochemical analysis of paraffin-embedded lung cancer tissues using CRK antibody Cat.-No AM06668SU-N with DAB staining.
AM06668SU-N - CRK
Immunohistochemical analysis of paraffin-embedded intima cancer tissues using CRK antibody Cat.-No AM06668SU-N with DAB staining.
AM06668SU-N - CRK
Immunofluorescence analysis of 3T3-L1 cells using CRK antibody Cat.-No AM06668SU-N (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.
AM06668SU-N - CRK
Flow Cytometric analysis of Hela cells using CRK antibody Cat.-No AM06668SU-N (blue) and negative control (red).
CPA3185-100ul - CRK
Immunohistochemical analysis of CRK staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
CPA3185-100ul - CRK
Western blot analysis of CRK expression in HeLa (A); K562 (B); NIH3T3 (C) whole cell lysates.
TP301701 - CRK
TP303438 - CRK
TA325390 - CRK
Western blot analysis of CrkII expression in COS7 whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
TA349831 - CRK
The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using (CRK Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: ×200)
  1. Quick-Filters:
  2. Highly Validated (remove)
Clear All Quick-Filters

2 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

CRK antibody
Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using CRK mouse mAb with DAB staining. Mouse IgG2b 3G11C1 Ascites Hu E, ICC/IF, P, WB
0.1 ml / $410.00
  OriGene Technologies GmbH
+6 additional images

Highly validated antibody!

CRK antibody
Immunohistochemical analysis of paraffin-embedded lung cancer tissues using CRK antibody Cat.-No AM06668SU-N with DAB staining. Mouse IgG2b 3G11E8 Ascites Hu E, ICC/IF, P, WB
0.1 ml / $410.00
  OriGene Technologies GmbH
+3 additional images

Highly validated antibody!

2 Item(s)

per page

Available Filters

Product Type
  1. Primary Antibody (2)
Clonality
  1. Monoclonal (2)
Target
  1. CRK (2)
Reactivity
  1. Human (Hu) (2)
Applications
  1. Enzyme Immunoassay (E) (2)
  2. Immunocytochemistry/​Immunofluorescence (ICC/IF) (2)
  3. Paraffin Sections (P) (2)
  4. Western blot / Immunoblot (WB) (2)
Presentation
  1. Ascites (2)
Host
  1. Mouse (2)
Images
  1. 1 image (2)
  2. 3+ images (2)
  3. 5+ images (1)
Images: Applications
  1. Flow cytometry (F) (2)
  2. Immunocytochemistry/​Immunofluorescence (ICC/IF) (2)
  3. Paraffin Sections (P) (2)
  4. Enzyme Immunoassay (E) (1)
  5. Western blot / Immunoblot (WB) (1)
Manufacturer
  1. OriGene Technologies (2)
Service
 
© Copyright 1998 - 2018 OriGene Technologies, Inc.
  • LinkedIn